Tuesday, March 18, 2025 at 11:00 AM
March 18th, 2025 1.00 AMA PRA Category 1 Credit Hours
Description
The latest clinical translational research strategies that show promise for profound ASD.
Streams
| Name | |
|---|---|
| You must be signed in to view streams. Click here to sign into your Stony Brook Medicine CME Account. |
Dates and Times
Start: 3/18/2025 11:00 AM
End: 3/18/2025 12:00 PM
Objectives
1. The audience will understand the defining characteristics of the proposed diagnostic category of profound autism
2. The audience will be able to identify how the genetics of this proposed subgroup differs from that of the broad ASD population
3. The audience will recognize two distinctive clinical translational research strategies that show particular promise for profound ASD
Grand Round Files
| File | Link |
|---|---|
|
RefsDrStatePsychiatryGrandRoundsMarch182025 Dr. Matthew State references for Psychiatry & Behavioral Health Grand Rounds March 18, 2025 |
Download |
Speakers
Accreditation
The School of Medicine, State University of New York at Stony Brook, is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
The School of Medicine, State University of New York at Stony Brook designates this live activity for a maximum of 1.00 AMA PRA Category 1 Credits ™. Physicians should only claim the credit commensurate with the extent of their participation in the activity.
Disclosure
Among all the planners, speakers, and reviewers for this educational activity only:
- Matthew State, MD
| Speaker | Company | Relationship |
|---|---|---|
| Matthew State, MD | ||
| Maplight Therapeutics | Scientific Advisory Board Member | |
| Neumora | Stock | |
All of the relevant financial relationships listed for the above individual(s) have been mitigated.
Need help with this Grand Round Session?
Please contact the Grand Round coordinator listed below:
Mary Carlson
Department: Psychiatry
Phone: (631) 444-2767
Email: Mary.carlson@stonybrookmedicine.edu